Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1774-1783
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1774
Table 2 Discriminative performance of the various risk prediction scores calculated at baseline and after 1 year of ursodeoxycholic acid therapy
C-statistic at various follow-up time points (95%CI)
Risk prediction model
Baseline
1 yr of UDCA
GLOBE0.731 (0.681-0.782)
UK-PBC0.727 (0.678-0.776)
APRI0.592 (0.536-0.647)0.347 (0.296-0.398)
FIB40.648 (0.593-0.704)0.680 (0.628-0.732)
ALBI0.705 (0.656-0.755)0.725 (0.672-0.778)
Mayo0.702 (0.653-0.751)0.740 (0.690-0.791)